BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 99 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |
| AlphaCentric Advisors LLC | 58,500 | $1,175,265 | 0.67% |
| AtonRa Partners | 11,588 | $232,803 | 0.49% |
| Parkman Healthcare Partners LLC | 122,721 | $2,465,465 | 0.45% |
| Leucadia National | 1,948,000 | $39,135,320 | 0.35% |
| RA Capital Management | 800,000 | $16,072,000 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $20,090,000 | 0.31% |
| Camber Capital Management LP | 400,000 | $8,036 | 0.26% |
| Alpha DNA Investment Management LLC | 27,957 | $561,657 | 0.23% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 285,479 | $5,735,273 | 0.22% |
| Verition Fund Management LLC | 916,382 | $18,410,114 | 0.22% |
External links
This page lists BICYCLE THERAPEUTICS PLC's shareholders in Q3 2023. To view BICYCLE THERAPEUTICS PLC's shareholder history, click here.